Henry Schein, Inc. (LON:0L3C)
63.60
+0.03 (0.05%)
At close: Oct 28, 2025
Henry Schein Revenue
Henry Schein had revenue of $3.24B USD in the quarter ending June 28, 2025, with 3.32% growth. This brings the company's revenue in the last twelve months to $12.77B, up 2.29% year-over-year. In the year 2024, Henry Schein had annual revenue of $12.67B with 2.71% growth.
Revenue (ttm)
$12.77B
Revenue Growth
+2.29%
P/S Ratio
0.62
Revenue / Employee
$510.92K
Employees
25,000
Market Cap
5.77B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 12.67B | 334.00M | 2.71% |
| Dec 30, 2023 | 12.34B | -308.00M | -2.44% |
| Dec 31, 2022 | 12.65B | 246.00M | 1.98% |
| Dec 25, 2021 | 12.40B | 2.28B | 22.55% |
| Dec 26, 2020 | 10.12B | 133.20M | 1.33% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 26, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Henry Schein News
- 6 days ago - Henry Schein to Participate in Upcoming Investor Conferences in November - Business Wire
- 7 days ago - Henry Schein to Webcast Third Quarter 2025 Conference Call on Tuesday, November 4, 2025, at 8:00 A.M. ET - Business Wire
- 13 days ago - The Aspen Group Enhances Patient Experience with Planmeca Digital Imaging at Aspen Dental Locations Nationwide - PRNewsWire
- 22 days ago - July 2026 Options Now Available For Henry Schein (HSIC) - Nasdaq
- 26 days ago - Peering Into Henry Schein Inc's Recent Short Interest - Benzinga
- 4 weeks ago - Henry Schein, Inc. (HSIC) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Henry Schein Sees Steady Smile As Dental Market Growth Holds: Analyst - Benzinga
- 5 weeks ago - Barrington Research Maintains Henry Schein (HSIC) Rating and Price Target | HSIC Stock News - GuruFocus